Exon-Skipping Antisense Oligonucleotides to Correct Missplicing in Neurogenetic Diseases

被引：61

作者：

Siva, Kavitha ^{[1
]}

Covello, Giuseppina ^{[1
]}

Denti, Michela A. ^{[1
,2
]}

机构：

[1] Univ Trento, Ctr Integrat Biol CIBIO, I-38123 Trento, Italy

[2] CNR, Inst Neurosci, Padua, Italy

来源：

NUCLEIC ACID THERAPEUTICS | 2014年 / 24卷 / 01期

关键词：

RESTORES DYSTROPHIN EXPRESSION; AMYLOID PRECURSOR PROTEIN; SPINAL MUSCULAR-ATROPHY; PEPTIDE NUCLEIC-ACID; PELIZAEUS-MERZBACHER-DISEASE; RECEPTOR-ALPHA CHAIN; BLOOD-BRAIN-BARRIER; BETA-TRACE PROTEIN; LONG-TERM RESCUE; MDX MICE;

D O I：

10.1089/nat.2013.0461

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Alternative splicing is an important regulator of the transcriptome. However, mutations may cause alteration of splicing patterns, which in turn leads to disease. During the past 10 years, exon skipping has been looked upon as a powerful tool for correction of missplicing in disease and progress has been made towards clinical trials. In this review, we discuss the use of antisense oligonucleotides to correct splicing defects through exon skipping, with a special focus on diseases affecting the nervous system, and the latest stage achieved in its progress.

引用

页码：69 / 86

页数：18

共 133 条

[1] Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cells [J].

Aartsma-Rus, A ;

Kaman, WE ;

Bremmer-Bout, M ;

Janson, AAM ;

den Dunnen, JT ;

van Ommen, GJB ;

van Deutekom, JCT .

GENE THERAPY, 2004, 11 (18) :1391-1398

[2] Antisense-mediated exon skipping: A versatile tool with therapeutic and research applications [J].

Aartsma-Rus, Annemieke ;

Van Ommen, Gert-Jan B. .

RNA, 2007, 13 (10) :1609-1624

[3]

Aartsma-Rus A, 2012, METHODS MOL BIOL, V867, P97, DOI 10.1007/978-1-61779-767-5_7

[4] Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents [J].

Abes, Said ;

Moulton, Hong M. ;

Clair, Philippe ;

Prevot, Paul ;

Youngblood, Derek S. ;

Wu, Rebecca P. ;

Iversen, Patrick L. ;

Lebleu, Bernard .

JOURNAL OF CONTROLLED RELEASE, 2006, 116 (03) :304-313

[5] Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology [J].

Alter, J ;

Lou, F ;

Rabinowitz, A ;

Yin, HF ;

Rosenfeld, J ;

Wilton, SD ;

Partridge, TA ;

Lu, QL .

NATURE MEDICINE, 2006, 12 (02) :175-177

[6] Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate [J].

Amantana, Adams ;

Moulton, Hong M. ;

Cate, Melissa L. ;

Reddy, Muralimohan T. ;

Whitehead, Tom ;

Hassinger, Jed N. ;

Youngblood, Derek S. ;

Iversen, Patrick L. .

BIOCONJUGATE CHEMISTRY, 2007, 18 (04) :1325-1331

[7] Tau splicing and the intricacies of dementia [J].

Andreadis, Athena .

JOURNAL OF CELLULAR PHYSIOLOGY, 2012, 227 (03) :1220-1225

[8] Antisense Oligonucleotide-Mediated Exon Skipping for Duchenne Muscular Dystrophy: Progress and Challenges [J].

Arechavala-Gomeza, Virginia ;

Anthony, Karen ;

Morgan, Jennifer ;

Muntoni, Francesco .

CURRENT GENE THERAPY, 2012, 12 (03) :152-160

[9] Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2′-O-methyl/LNA oligoribonucleotides [J].

Arzumanov, A ;

Walsh, AP ;

Rajwanshi, VK ;

Kumar, R ;

Wengel, J ;

Gait, MJ .

BIOCHEMISTRY, 2001, 40 (48) :14645-14654

[10] DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation [J].

Bakkenist, CJ ;

Kastan, MB .

NATURE, 2003, 421 (6922) :499-506

← 1 2 3 4 5 6 7 8 9 10 →